Register to leave comments

  • News bot Aug. 18, 2026, 1:54 a.m.

    🔍 Tansey Casey M (Executive)

    Company: Mobia Medical, Inc. (MOBI)

    Report Date: 2026-08-13

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 68,559

    Detailed Transactions and Holdings:

    • Acquired 35,572 shares of Common Stock at $11.5073 per share (Direct)
      Date: 2026-08-13 | Code: P | equity_swap_involved: false | shares_owned_after: 268,904.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 15,721 shares of Common Stock at $11.65 per share (Direct)
      Date: 2026-08-14 | Code: P | equity_swap_involved: false | shares_owned_after: 284,625.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 100 shares of Common Stock at $12.53 per share (Direct)
      Date: 2026-08-14 | Code: P | equity_swap_involved: false | shares_owned_after: 284,725.00 | transaction_form_type: 4
    • Acquired 17,166 shares of Common Stock at $11.8509 per share (Direct)
      Date: 2026-08-17 | Code: P | equity_swap_involved: false | shares_owned_after: 301,891.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.33 to $11.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
    • F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.42 to $12.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
    • F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.675 to $12.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.